arrow
K

Kathryn Dahir

AstraZeneca
H指数:21
被引数:1,434

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Biochemical phenotype of hypophosphatasia in asymptomatic individuals carrying ALPL variants

低磷酸酯酶症患者携带ALPL变异体的生化表型

2025-10-010
OAAI
Characterization of flare-ups and impact of garetosmab in adults with fibrodysplasia ossificans progressiva: a post hoc analysis of the randomized, double-blind, placebo-controlled LUMINA-1 trial
2024-08-311
OAAI
Nephrocalcinosis and kidney function in children and adults with X-linked hypophosphatemia: baseline results from a large longitudinal study
2024-08-161
OAAI
Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study

Settrusumab用于治疗成骨不全症: 2b期小行星研究的12个月结果

2024-07-168
PRE
An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH)
2024-05-013
PRE
Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults (vol 35, pg 431, 2023)
2024-03-181
OAAI
The Global ALPL gene variant classification project: Dedicated to deciphering variants
BONE
IF3.6
2024-01-0123
OAAI
The challenge of hypophosphatasia diagnosis in adults: results from the HPP International Working Group Literature Surveillance
2023-11-205
PRE